Cansino Biologics Stock Market Value
| CASBF Stock | USD 3.37 0.07 2.12% |
| Symbol | CanSino |
CanSino Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CanSino Biologics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CanSino Biologics.
| 12/22/2024 |
| 01/21/2025 |
If you would invest 0.00 in CanSino Biologics on December 22, 2024 and sell it all today you would earn a total of 0.00 from holding CanSino Biologics or generate 0.0% return on investment in CanSino Biologics over 30 days. CanSino Biologics is related to or competes with Canopy Growth, Aurora Cannabis, SNDL, and Cronos. CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China More
CanSino Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CanSino Biologics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CanSino Biologics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 26.77 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 2.12 |
CanSino Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CanSino Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CanSino Biologics' standard deviation. In reality, there are many statistical measures that can use CanSino Biologics historical prices to predict the future CanSino Biologics' volatility.| Risk Adjusted Performance | 0.0051 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.1) | |||
| Treynor Ratio | 0.0604 |
CanSino Biologics Backtested Returns
CanSino Biologics secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. CanSino Biologics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CanSino Biologics' Risk Adjusted Performance of 0.0051, mean deviation of 1.15, and Standard Deviation of 3.33 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.32, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CanSino Biologics are expected to decrease at a much lower rate. During the bear market, CanSino Biologics is likely to outperform the market. At this point, CanSino Biologics has a negative expected return of -0.0104%. Please make sure to confirm CanSino Biologics' skewness, and the relationship between the total risk alpha and rate of daily change , to decide if CanSino Biologics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.35 |
Below average predictability
CanSino Biologics has below average predictability. Overlapping area represents the amount of predictability between CanSino Biologics time series from 22nd of December 2024 to 6th of January 2025 and 6th of January 2025 to 21st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CanSino Biologics price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current CanSino Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
CanSino Biologics lagged returns against current returns
Autocorrelation, which is CanSino Biologics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CanSino Biologics' pink sheet expected returns. We can calculate the autocorrelation of CanSino Biologics returns to help us make a trade decision. For example, suppose you find that CanSino Biologics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CanSino Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CanSino Biologics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CanSino Biologics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CanSino Biologics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
CanSino Biologics Lagged Returns
When evaluating CanSino Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CanSino Biologics pink sheet have on its future price. CanSino Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CanSino Biologics autocorrelation shows the relationship between CanSino Biologics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in CanSino Biologics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in CanSino Pink Sheet
CanSino Biologics financial ratios help investors to determine whether CanSino Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CanSino with respect to the benefits of owning CanSino Biologics security.